Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation
Blood Cancer J
.
2013 Aug 30;3(8):e136.
doi: 10.1038/bcj.2013.35.
Authors
C Schönefeldt
1
,
K Sockel
,
R Wehner
,
S Sopper
,
D Wolf
,
M Wermke
,
C Thiede
,
U Oelschlägel
,
G Ehninger
,
M Bornhäuser
,
U Platzbecker
,
M Schmitz
Affiliation
1
Medical Clinic I, University Hospital Carl Gustav Carus, Dresden, Germany.
PMID:
23995045
PMCID:
PMC3763388
DOI:
10.1038/bcj.2013.35
No abstract available